PB2415: THE ROLE OF NUTRITIONAL SUPPORT DURING AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN LYMPHOMA.

PB2415: THE ROLE OF NUTRITIONAL SUPPORT DURING AUTOLOGOUS STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN LYMPHOMA.

Bibliographic Details
Main Authors:	Stanislav Volchenkov, Larisa Filatova, Ishmatova Irina, Ilya Zyuzgin, Zverkova Anna, Svetlana Elkhova, Aleksei Koviazin, Tatiana Semiglazova, Leonid Kramynin, Nikulina July, Dobrovolskaya Evgenia
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000976368.13179.db

Similar Items

P1384: EFFECT OF NUTRITIONAL SUPPORT ON THE INCIDENCE OF MUCOSITIS IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN’S LYMPHOMA. (INTERIM RESULTS)
by: S. Volchenkov, et al.
Published: (2022-06-01)

P1316: INCREASED EFFICACY OF INTERMEDIATE-DOSE ARAC+G-CSF COMPARED TO CY+G-CSF AND PLERIXAFOR+G-CSF AS A STEM CELL MOBILIZATION REGIMEN IN POOR MOBILIZERS WITH HEMATOLOGICAL MALIGNANCIES
by: Svetlana Elkhova, et al.
Published: (2023-08-01)

P1285: IMPROVING THE EFFECTIVENESS OF FIRST-LINE THERAPY FOR STAGE IV DIFFUSE LARGE B-CELL LYMPHOMA WITH UPFRONT AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION.
by: Aleksei Koviazin, et al.
Published: (2023-08-01)

P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL
by: A. Koviazin, et al.
Published: (2022-06-01)

The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma
by: Aleksei K. Koviazin, et al.
Published: (2023-04-01)

Short- and long-term outcomes from the upfront high-dose chemotherapy, followed by autologous hematopoietic stem cell transplantation in diffuse large B-cell lymphoma
by: A. K. Koviazin, et al.
Published: (2022-06-01)

Features of nutritional support during stem cell transplantation
by: S. A. Volchenkov, et al.
Published: (2020-07-01)

Pretransplant hypoalbuminemia may be associated with poor survival in patients that underwent autologous hematopoietic stem cell transplantation (autoHSCT)
by: Serdar Sivgin, et al.
Published: (2014-08-01)

Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation (autoHSCT)
by: Serdar Sivgin
Published: (2013-01-01)

The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
by: M S Motalkina, et al.
Published: (2015-06-01)

Computational Analysis of the 2415-3S Airfoil Aerodynamic Performance
by: Luis Velázquez-Araque, et al.
Published: (2014-02-01)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN CLL: FIRST RESULTS OF AN EBMT RANDOMIZED TRIAL COMPARING AUTOTRANSPLANT VERSUS WAIT AND WATCH
by: Michallet, M, et al.
Published: (2010)

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch
by: Michallet, M, et al.
Published: (2009)

Parametric investigation on the aerodynamic characteristic of NACA2415 airfoil at low reynolds number
by: Muhammad Hafizuddin, Ismail
Published: (2013)

Analysis of Air Flow Past and through the 2415-3S Airfoil for an Unmanned Aerial Vehicle with Internal Propulsion System
by: Luis D. Mendoza, et al.
Published: (2014-08-01)

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2<sup>nd</sup> line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
by: A. A. Mamedova, et al.
Published: (2022-07-01)

Autologous Stem Cell Transplant in Hodgkin’s and Non-Hodgkin’s Lymphoma, Multiple Myeloma, and AL Amyloidosis
by: Sulaiman Mohammed Alnasser, et al.
Published: (2023-12-01)

Corrigendum to "Brown carbon absorption linked to organic mass tracers in biomass burning particles" published in Atmos. Chem. Phys., 13, 2415–2422, 2013
by: D. A. Lack, et al.
Published: (2013-03-01)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
by: Afonso José Pereira Cortez, et al.
Published: (2011-02-01)

Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
by: Eva Domingo-Domènech, et al.
Published: (2020-05-01)

Autologous stem-cell transplantation in Hodgkin's lymphoma: analysis of a therapeutic option
by: Adriano de Moraes Arantes, et al.

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin
by: Adrian Schmidt
Published: (2020-11-01)

Autologous Stem Cell Transplantation in Hodgkin Lymphoma—Latest Advances in the Era of Novel Therapies
by: Yazeed Samara, et al.
Published: (2022-03-01)

Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma
by: Jaco A. C. van Bruggen, et al.
Published: (2020-12-01)

Autologous hematopoetic stem cell transplantation for HIV-related Non-Hodgkin's Lymphomas (NHL)
by: Henrique Bittencourt

Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
by: Zachary Jackson, et al.
Published: (2020-08-01)

Erratum: Yoshimi, Y., <i>et al.</i> Size of Heparin-Imprinted Nanoparticles Reflects the Matched Interactions with the Target Molecule. <i>Sensors</i> 2019, <i>19</i>, 2415
by: Yasuo Yoshimi, et al.
Published: (2019-08-01)

Linfoma de Hodgkin recidivado após transplante autólogo de medula óssea Relapsed Hodgkin's lymphoma after autologous bone marrow transplantation
by: Abrahão E. Hallack Neto, et al.
Published: (2008-08-01)

Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant
by: Aung M. Tun, et al.
Published: (2023-04-01)

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA
by: V. G. Potapenko, et al.
Published: (2017-01-01)

Plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation
by: Jan S. Moreb
Published: (2011-10-01)

EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
by: Jhanzeb Iftikhar, et al.
Published: (2021-10-01)

AuNP Aptasensor for Hodgkin Lymphoma Monitoring
by: Maria Slyusarenko, et al.
Published: (2022-01-01)

PB2316: SAFETY AND EFFICACY OF AUTOLOGOUS HSCT IN NINE PATIENTS WITH AIDS-RELATED NON-HODGKIN LYMPHOMA
by: Jun Liu, et al.
Published: (2023-08-01)

Outcomes of Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma Patients at a Tertiary Referral Centre
by: Ajay Prakash, et al.
Published: (2023-04-01)

Clinical Efficacy and Prognostic Factors of Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma in 38 Cases
by: HUANG Zhenghua, et al.
Published: (2022-09-01)

Outcomes of Refractory and Relapsed Hodgkin Lymphoma With Autologous Stem-Cell Transplantation: A Single Institution Experience
by: Rabia Wali, et al.
Published: (2019-11-01)

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
by: Anna Sureda, et al.
Published: (2020-11-01)

The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/ Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: “A Single-Center Experience”
by: Ali Eser, et al.
Published: (2021-05-01)

AUTOLOGOUS HEMATOPOIETC CELL TRANSPLANTATION (HCT) FOR HODGKIN LYMPHOMA, REAL WORLD EXPERIENCE OF A SINGLE CENTER EXPERIENCE
by: Carmino De Souza, et al.
Published: (2023-10-01)